Literature DB >> 22366929

[Physicians do not treat averages--but therapy responders!].

C Maier, R Baron.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22366929     DOI： 10.1007/s00482-011-1134-0

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  20 in total

Review 1.  Personalized therapy in pain management: where do we stand?

Authors:  Ulrike M Stamer; Lan Zhang; Frank Stüber
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

Review 2.  Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy.

Authors:  Robert H Dworkin; Dennis C Turk; Ethan Basch; Ann Berger; Charles Cleeland; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Robert D Kerns; John Markman; Linda Porter; Srinivasa N Raja; Edgar Ross; Knox Todd; Mark Wallace; Clifford J Woolf
Journal:  Pain       Date:  2011-03-10       Impact factor: 6.961

Review 3.  Patients' direct experiences as central elements of placebo analgesia.

Authors:  Lene Vase; Kathrine Næsted Nørskov; Gitte Laue Petersen; Donald D Price
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  [Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment].

Authors:  C Maier; C Schaub; A Willweber-Strumpf; M Zenz
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

5.  Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems.

Authors:  Henry McQuay; Dawn Carroll; Andrew Moore
Journal:  Pain       Date:  1996-02       Impact factor: 6.961

Review 6.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 7.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

8.  Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

Authors:  Christoph Maier; Jan Hildebrandt; Regine Klinger; Christine Henrich-Eberl; Gabriele Lindena
Journal:  Pain       Date:  2002-06       Impact factor: 6.961

9.  Pregabalin in fibromyalgia--responder analysis from individual patient data.

Authors:  Sebastian Straube; Sheena Derry; R Andrew Moore; Jocelyn Paine; Henry J McQuay
Journal:  BMC Musculoskelet Disord       Date:  2010-07-05       Impact factor: 2.362

10.  Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.

Authors:  Eija Kalso; Karen H Simpson; Robert Slappendel; Joachim Dejonckheere; Ute Richarz
Journal:  BMC Med       Date:  2007-12-21       Impact factor: 8.775
View more
  1 in total

Review 1.  [Psychotherapeutic procedures for fibromyalgia syndrome].

Authors:  W Häuser; K Bernardy
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.